Acne and systemic disease.
Acne is the most common disease of the skin. It affects 85% of teenagers, 42.5% of men, and 50.9% of women between the ages of 20 and 30 years.96,97 The role of hormones, particularly as a trigger of sebum production and sebaceous growth and differentiation, is well known. Excess production of hormones, specifically androgens, GH, IGF-1, insulin, CRH, and glucocorticoids, is associated with increased rates of acne development. Acne may be a feature in many endocrine disorders, including polycystic ovary disease, Cushing syndrome, CAH, androgen-secreting tumors, and acromegaly. Other nonendocrine diseases associated with acne include Apert syndrome, SAPHO syndrome, Behçet syndrome and PAPA syndrome. Acne medicamentosa is the development of acne vulgaris or an acneiform eruption with the use of certain medications. These medications include testosterone, progesterone,steroids, lithium, phenytoin, isoniazid, vitamins B2, B6, and B12, halogens, and epidermal growth factor inhibitors. Management of acne medicamentosa includes standard acne therapy. Discontinuation of the offending drug may be necessary in recalcitrant cases. Basic therapeutic interventions for acne include topical therapy, systemic antibiotics,hormonal agents, isotretinoin, and physical treatments. Generally, the severity of acne lesions determines the type of acne regimen necessary. The emergence of drug-resistant P acnes and adverse side effects are current limitations to effective acne management.
Lolis
Margarita S
MS
Department of Dermatology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
Bowe
Whitney P
WP
Shalita
Alan R
AR
D000152:Acne Vulgaris / Q000209:etiology* / Q000378:metabolism / Q000628:therapy*; D020083:Acquired Hyperostosis Syndrome / Q000150:complications; D000168:Acrocephalosyndactylia / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications; D003879:Dermatologic Agents / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D004700:Endocrine System Diseases / Q000150:complications; D006728:Hormones / Q000096:biosynthesis / Q000627:therapeutic use; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D028022:Low-Level Light Therapy; D010789:Phototherapy
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D006728:Hormones; D015474:Isotretinoin